FORMA THERAPEUTICS HLDGS INC's ticker is FMTX and the CUSIP is 34633R104.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $1,860,000 | +189.7% | 93,236 | 0.0% | 0.00% | +100.0% |
| Q2 2022 | $642,000 | -26.0% | 93,236 | 0.0% | 0.00% | 0.0% |
| Q1 2022 | $867,000 | -34.6% | 93,236 | 0.0% | 0.00% | 0.0% |
| Q4 2021 | $1,325,000 | -38.7% | 93,236 | 0.0% | 0.00% | -50.0% |
| Q3 2021 | $2,162,000 | -6.8% | 93,236 | 0.0% | 0.00% | 0.0% |
| Q2 2021 | $2,320,000 | -11.2% | 93,236 | 0.0% | 0.00% | -50.0% |
| Q1 2021 | $2,613,000 | -19.3% | 93,236 | +0.5% | 0.00% | -20.0% |
| Q4 2020 | $3,238,000 | -30.0% | 92,786 | 0.0% | 0.01% | -37.5% |
| Q3 2020 | $4,624,000 | – | 92,786 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Samsara BioCapital, LLC | 1,565,526 | $36,305,000 | 5.70% |
| Cormorant Asset Management, LP | 4,720,495 | $109,468,000 | 4.45% |
| Logos Global Management LP | 2,115,000 | $49,047,000 | 3.54% |
| RA Capital Management | 9,011,651 | $208,980,000 | 2.90% |
| Opaleye Management Inc. | 182,950 | $4,243,000 | 0.79% |
| Artal Group S.A. | 1,000,000 | $23,190,000 | 0.52% |
| HighVista Strategies LLC | 26,711 | $619,000 | 0.41% |
| Integral Health Asset Management, LLC | 60,000 | $1,391,000 | 0.40% |
| HHLR ADVISORS, LTD. | 1,100,000 | $25,509,000 | 0.33% |
| Baker Brothers Advisors | 2,024,876 | $46,957,000 | 0.21% |